Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David O'Callaghan

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Journal of Bacteriology|February 10, 2009
Interplay between two RND systems mediating antimicrobial resistance in Brucella suisFernando A Martin, Diana M Posadas, Mariela C Carrica, et al.
Cell Communication and Signaling : CCS|October 12, 2014
The Brucella TIR domain containing proteins BtpA and BtpB have a structural WxxxE motif important for protection against microtubule depolymerisationChristine Felix, Burcu Kaplan Türköz, Sebastien Ranaldi, et al.
The Journal of Infectious Diseases|December 16, 2014
Brucella Intracellular Life Relies on the Transmembrane Protein CD98 Heavy ChainAnne Keriel, Eric Botella, Soline Estrach, et al.
Journal of Bacteriology|November 11, 2015
Transcriptome-Wide Identification of Hfq-Associated RNAs in Brucella suis by Deep SequencingBashir Saadeh, Clayton C Caswell, Yanjie Chao, et al.
Infection and Immunity|August 23, 2005
Identification of a new virulence factor, BvfA, in Brucella suisJean-Philippe Lavigne, Gilles Patey, Felix J Sangari, et al.
Intensive Care Medicine|February 5, 2020
Methylnaltrexone for the treatment of opioid-induced constipation and gastrointestinal stasis in intensive care patients. Results from the MOTION trialParind B Patel, Stephen J Brett, David O'Callaghan, et al.
BMJ Open|July 15, 2016
Protocol for a randomised control trial of methylnaltrexone for the treatment of opioid-induced constipation and gastrointestinal stasis in intensive care patients (MOTION)Parind B Patel, Stephen J Brett, David O'Callaghan, et al.
FEBS Letters|October 1, 2013
Structure of the Toll/interleukin 1 receptor (TIR) domain of the immunosuppressive Brucella effector BtpA/Btp1/TcpBBurcu Kaplan-Türköz, Thomas Koelblen, Christine Felix, et al.
Plos Neglected Tropical Diseases|September 5, 2024
Diagnosis of brucellosis: Combining tests to improve performancePaul Loubet, Chloé Magnan, Florian Salipante, et al.
Frontiers in Molecular Biosciences|May 21, 2016
A Functional oriT in the Ptw Plasmid of Burkholderia cenocepacia Can Be Recognized by the R388 Relaxase TrwCEsther Fernández-González, Sawsane Bakioui, Margarida C Gomes, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Journal of Bacteriology|February 10, 2009
Interplay between two RND systems mediating antimicrobial resistance in Brucella suisFernando A Martin, Diana M Posadas, Mariela C Carrica, et al.
Cell Communication and Signaling : CCS|October 12, 2014
The Brucella TIR domain containing proteins BtpA and BtpB have a structural WxxxE motif important for protection against microtubule depolymerisationChristine Felix, Burcu Kaplan Türköz, Sebastien Ranaldi, et al.
The Journal of Infectious Diseases|December 16, 2014
Brucella Intracellular Life Relies on the Transmembrane Protein CD98 Heavy ChainAnne Keriel, Eric Botella, Soline Estrach, et al.
Journal of Bacteriology|November 11, 2015
Transcriptome-Wide Identification of Hfq-Associated RNAs in Brucella suis by Deep SequencingBashir Saadeh, Clayton C Caswell, Yanjie Chao, et al.
Infection and Immunity|August 23, 2005
Identification of a new virulence factor, BvfA, in Brucella suisJean-Philippe Lavigne, Gilles Patey, Felix J Sangari, et al.
Intensive Care Medicine|February 5, 2020
Methylnaltrexone for the treatment of opioid-induced constipation and gastrointestinal stasis in intensive care patients. Results from the MOTION trialParind B Patel, Stephen J Brett, David O'Callaghan, et al.
BMJ Open|July 15, 2016
Protocol for a randomised control trial of methylnaltrexone for the treatment of opioid-induced constipation and gastrointestinal stasis in intensive care patients (MOTION)Parind B Patel, Stephen J Brett, David O'Callaghan, et al.
FEBS Letters|October 1, 2013
Structure of the Toll/interleukin 1 receptor (TIR) domain of the immunosuppressive Brucella effector BtpA/Btp1/TcpBBurcu Kaplan-Türköz, Thomas Koelblen, Christine Felix, et al.
Plos Neglected Tropical Diseases|September 5, 2024
Diagnosis of brucellosis: Combining tests to improve performancePaul Loubet, Chloé Magnan, Florian Salipante, et al.
Frontiers in Molecular Biosciences|May 21, 2016
A Functional oriT in the Ptw Plasmid of Burkholderia cenocepacia Can Be Recognized by the R388 Relaxase TrwCEsther Fernández-González, Sawsane Bakioui, Margarida C Gomes, et al.
Pageof 7